Erzincan Binali Yıldırım ÜniversitesiErzincan Binali Yıldırım ÜniversitesiAçık Erişim Arşivi · RDL Open

Corrigendum to “What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?” [Int. Immunopharmacol. 105 (2022) 108542](S1567576923011463)(10.1016/j.intimp.2023.110821)

CorrectionAçık Erişim

Özet

The authors regretted writing the ethical approval number of the article incorrectly. This study was approved by Erzincan Binali Yıldırım University Non-Interventional Clinical Research Ethics Committee (Reference No: 28.05.2021, 13–15) The authors would like to apologize for any inconvenience caused. © 2024 Elsevier B.V.

Anahtar Kelimeler

erratumhumantherapydrug therapy
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11136Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorHuyut, Mehmet Tahir
dc.contributor.authorHuyut, Zübeyir
dc.contributor.authorIlkbahar, Fatih
dc.contributor.authorMertoğlu, Cuma
dc.date.accessioned2026-10-18T20:26:13.990593905Z
dc.date.available2026-10-18T20:26:13.990593905Z
dc.date.issued2025
dc.description.abstractThe authors regretted writing the ethical approval number of the article incorrectly. This study was approved by Erzincan Binali Yıldırım University Non-Interventional Clinical Research Ethics Committee (Reference No: 28.05.2021, 13–15) The authors would like to apologize for any inconvenience caused. © 2024 Elsevier B.V.
dc.identifier.doi10.1016/j.intimp.2024.113814
dc.identifier.eissn1878-1705
dc.identifier.issn1567-5769
dc.identifier.pmid39743454
dc.identifier.scopus2-s2.0-85213943490
dc.identifier.startpage113814
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11136
dc.identifier.volume146
dc.identifier.wosWOS:001399974100001
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Immunopharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjecterratum
dc.subjecthuman
dc.subjecttherapy
dc.subjectdrug therapy
dc.titleCorrigendum to “What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?” [Int. Immunopharmacol. 105 (2022) 108542](S1567576923011463)(10.1016/j.intimp.2023.110821)
dc.typeCorrection
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.wos0
rdl.departmentErzincan Binali Yıldırım University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Erzincan, Türkiye. Electronic address: tahir.huyut@erzincan.edu.tr. | Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Clinical Biochemistry, Erzincan, Türkiye
rdl.departmentInonu University, Faculty of Medicine, Department of Clinical Biochemistry, Malatya, Türkiye.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)